Compare Immunovant Inc. Common Stock (IMVT) vs Global X Defense Tech ETF (SHLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Global X Defense Tech ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Global X Defense Tech ETF trades at $59.92 (market cap $6.38B). The key difference: Immunovant Inc. Common Stock and Global X Defense Tech ETF are close in size by market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Global X Defense Tech ETF for 44 Days on average.
| IMVT | SHLD | |
|---|---|---|
Market Cap | $6.62B | $6.38B |
Volume | 1,131,364 | 1,280,546 |
Sector | Health | Sector/Thematic |
52-Week High | $44.96 | $78.02 |
52-Week Low | $17.03 | $58.20 |
Typical Hold Time | 0 Days | 44 Days |
Enterprise Value | $5.72B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SHLD (Global X Defense Tech ETF) trades at $58.74, down 2.2% on the day amid bearish technical signals. The ETF faces selling pressure with all 13 moving averages signaling bearish momentum, though oversold RSI readings at 10.99 (6-day) and 15.12 (12-day) suggest potential for near-term bounce. Recent institutional filings show increased buying interest from firms like Focus Financial Network (+55.4% stake) and Balefire LLC ($1.12M new position) in Q2 2026, indicating professional confidence in defense tech exposure.
The defense technology sector benefits from geopolitical tensions and rising global military budgets, with EU allies planning significant rearmament spending. However, the ETF's concentrated focus on emerging tech carries execution risks versus broader aerospace peers. Current technical weakness contrasts with fundamental tailwinds, creating a divergence that may resolve with either sector momentum recovery or continued ETF-specific pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Global X Defense Tech ETF
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →
